ArticleNature metabolism2026
Maternal obesity imprints methylation marks in oocytes to drive intergenerational metabolic dysfunction.
Article in Nature metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Maternal obesity predisposes offspring to metabolic disease, yet how oocytes transmit this risk remains unclear. Here, we show that maternal obesity induces locus-specific DNA methylation changes in oocytes to drive intergenerational metabolic dysfunction in a tissue-specific and sex-specific manner. Among these, a subset of metabolic genes, notably Hnf1α, Thra and Pdk4, exhibited persistent intergenerational methylation and transcriptional dysregulation. Although these methylation marks were erased during embryogenesis, H3K36me2 enrichment was retained at the loci, suggesting a potential chromatin-associated cue for methylation re-establishment. Single-CpG analysis identified regulatory landmarks correlating with gene expression, and conserved hypermethylation of HNF1A and THRA was also detected in oocytes from women with obesity. Using methylation-edited mouse models, we further demonstrated that targeted oocyte hypermethylation at Hnf1α enhanced hepatic gluconeogenesis in offspring, whereas Pdk4 hypermethylation impaired glucose tolerance, both in a female-biased manner. Together, our findings provide direct causal evidence that germline methylation at defined loci can programme intergenerational metabolic dysfunction, highlighting the preconception period as a critical window for potential intervention in humans.
Identifiers
42827194What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.